PMA device
Trilogy Transcatheter Heart Valve System
JenaValve Technology, Inc. · Aortic Valve, Prosthesis, Percutaneously Delivered (NPT, Class III) · First FDA decision Mar 17, 2026, newest May 18, 2026Aortic stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
Breakthrough-designated
Device trials
27
Naming "Trilogy"
MAUDE reports
55,426
Brand "Trilogy", since 2015
PubMed studies
858
Mentioning "Trilogy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Trilogy Transcatheter Heart Valve System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Trilogy Transcatheter Heart Valve SystemPMA supplement
P250024-S002 · Decided May 18, 2026 · 32 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- Trilogy Transcatheter Heart Valve SystemPMA supplement
P250024-S001 · Decided May 18, 2026 · 32 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- Trilogy Transcatheter Heart Valve SystemBreakthroughPMA
P250024 · Decided Mar 17, 2026 · 260 days after receipt
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430RUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430NUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR) for Aortic Regurgitation (AR)National analysisUnder reviewCAG-00430R3Updated Sep 14, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430R2Updated Sep 10, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National determinationOn the books20.32Updated Aug 16, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Trilogy", any status and sponsor, newest update first.
- ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™Pivotal-lookingRecruiting
JenaValve Technology, Inc.Not on our public-company list
NCT06608823 · 1,016 participants (planned) · Start Jun 18, 2025 · Primary completion Jun 2027
Device: Transcatheter Aortic Valve Replacement (TAVR) using Trilogy THV System; SAVR · For: Aortic Regurgitation; Aortic Valve Insufficiency; Aortic Insufficiency
Sites: Burlingame, California; La Jolla, California; Los Angeles, California · 40 sites in all
- The JenaValve ALIGN-AR LVAD RegistryActive, not recruiting
JenaValve Technology, Inc.Not on our public-company list
NCT06594705 · 50 participants · Start Dec 9, 2024 · Primary completion Aug 9, 2026
Device: JenaValve Trilogy Heart Valve System · For: Aortic Regurgitation; Aortic Valve Insufficiency; Aortic Insufficiency and 2 more
Sites: Los Angeles, California; San Francisco, California; Washington D.C., District of Columbia · 14 sites in all
- Trilogy Comparison Study - AdultsCompleted
Philips RespironicsPublic (PHG)
NCT00810498 · 11 participants · Start Mar 12, 2008 · Primary completion Feb 5, 2009
Device: Trilogy; Standard of Care · For: Respiratory Insufficiency; Respiratory Failure
Sites: Winnipeg, Canada
24 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Trilogy", and for the whole product code for context.
This brand
55,426 reports: 53,004 malfunction, 1,896 injury, 490 death
Whole product code NPT
77,669 reports: 12,243 malfunction, 57,723 injury, 7,693 death
Newest reports for this brand
- Trilogy 100Malfunction
2518422-2026-049094 · Received Oct 30, 2026 · Event dated Aug 27, 2026
Device type: Ventilator, Continuous, Facility Use (CBK)
Device problem as coded: Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Trilogy Evo, JapanMalfunction
2518422-2026-049096 · Received Oct 30, 2026 · Event dated Sep 18, 2026
Device type: Ventilator, Continuous, Facility Use (CBK)
Device problem as coded: No Display/Image
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Trilogy 100 Ventilator, U.S.A - BTMalfunction
2518422-2026-049084 · Received Oct 30, 2026 · Event dated Oct 2, 2026
Device type: Ventilator, Continuous, Facility Use (CBK)
Device problem as coded: Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- JenaValve Trilogy Delivery Catheter, Size 23MM REF: TRILOGY-DC-SOpen, Classified
Z-0134-2027 · Started Jul 31, 2026 · Posted by FDA Oct 9, 2026
Reason given: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
- JenaValve Trilogy Delivery Catheter, Size 25MM REF: TRILOGY-DC-MOpen, Classified
Z-0135-2027 · Started Jul 31, 2026 · Posted by FDA Oct 9, 2026
Reason given: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
- JenaValve Trilogy Delivery Catheter, Size 27MM REF: TRILOGY-DC-LOpen, Classified
Z-0136-2027 · Started Jul 31, 2026 · Posted by FDA Oct 9, 2026
Reason given: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Published research
The most relevant PubMed records for "Trilogy"[tiab]. The summary above synthesizes these.
- Electrocardiographic Trilogy.
Thakur RK, Natale A · Card Electrophysiol Clin · 2019Editorial, Introductory Journal Article
- Innovation: Metabolomics: the apogee of the omics trilogy.
Patti GJ, Yanes O, Siuzdak G · Nat Rev Mol Cell Biol · 2012Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Gut-Kidney-Heart: A Novel Trilogy.
Caldarelli M, Franza L, Rio P, et al. · Biomedicines · 2023Review
- ISCT Talking with Giants Trilogy.
Phinney DG · Cytotherapy · 2020
- Calmodulinopathy: a genetic trilogy.
George AL · Heart Rhythm · 2015Editorial, Research Support, N.I.H., Extramural
- A trilogy.
FORAKER AG · Perspect Biol Med · 1963
- Oncology: etymology of the term.
Janssen DF · Med Oncol · 2021Historical Article
- Electrocatalytic Hydrogen Production Trilogy.
Li Y, Wei X, Chen L, et al. · Angew Chem Int Ed Engl · 2021Review
- A peanut trilogy: polyploid origin, domestication, and genomic instability.
Jackson SA · Plant J · 2025Editorial
- On Bowlby's 'trilogy'.
Holmes J · Br J Psychiatry · 2013
- Cacao diseases-the trilogy revisited.
Evans HC · Phytopathology · 2007
- Words: a trilogy.
Perel ML · Implant Dent · 2008Editorial
Other devices of this type
Also filed under product code NPT.
- Sapien 3 Transcatheter Heart Valve and AccessoriesEdwards Lifesciences, LLC · PMA 2025
- Medtronic CoreValve Evolut R SystemMedtronic, Inc. · PMA 2022
- Edwards SAPIEN XT Transcatheter Heart ValveEdwards Lifesciences, LLC · PMA 2020
- Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart ValveEdwards Lifesciences, LLC · PMA 2026
- Medtronic CoreValve SystemMedtronic, Inc. · PMA 2023
- Edwards Sapien Transcatheter Heart Valve and Transfemoral and Transapical AccessoriesEdwards Lifesciences, LLC · PMA 2013
- Navitor Transcatheter Aortic Valve Implantation SystemAbbott Medical · PMA 2026
- LOTUS Edge Valve SystemBoston Scientific Corporation · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.